United Therapeutics financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$73.59M $115.92M $159.63M $210.94M $281.50M $358.88M $592.90M $743.18M $916.08M $1.12B $1.29B $1.47B $1.60B $1.73B $1.63B $1.45B $1.48B $1.69B $1.94B $2.33B $0.00M
GM % Gross Margin %
88.79% 89.38% 89.33% 89.45% 89.32% 88.61% 88.59% 88.04% 86.98% 88.26% 90.23% 95.29% 95.45% 93.87% 87.79% 91.88% 92.71% 92.73% 92.17% 88.94% 0.00%
OM Operating Margin
17.95% 37.00% 19.42% 2.99% 24.14% 8.43% 28.89% 43.43% 46.77% 26.19% 41.82% 47.69% 66.25% 59.26% 49.30% -12.26% 39.84% 40.75% 51.08% 50.96% 0.00%
EPS Earnings Per Share
$0.95 $1.31 $0.44 $1.22 $0.35 $1.85 $3.67 $5.78 $3.28 $6.48 $12.72 $16.00 $16.51 $15.36 $12.94 $14.46 $15.26 $16.71 $19.81 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0 0 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0
Sha. Shares
44.59m 46.23m 46.43m 42.54m 46.51m 53.84m 56.92m 58.34m 50.8m 50.23m 47.51m 45.63m 42.42m 43.21m 43.59m 43.88m 44.01m 44.54m 45.04m 46.99m 47.06m
OCF Operating Cash Flow
$20.78M $43.17M $49.26M $48.94M $-40.43M $99.72M $211.53M $250.20M $323.63M $425.27M $355.30M $382.80M $643.60M $474.20M $778.40M $-206.60M $755.70M $598.20M $802.50M $978.00M $0.00M
FCF Free Cash Flow
$15.56M $37.05M $33.63M $10.28M $-164.85M $4.32M $192.89M $214.22M $211.72M $393.36M $307.82M $332.97M $605.60M $387.90M $594.00M $-290.30M $696.40M $477.40M $663.70M $889.50M $0.00M
FCFS Free Cash Flow Per Share
$0.36 $0.81 $0.73 $0.24 $-3.60 $0.08 $3.44 $3.75 $4.06 $7.86 $6.39 $14.85 $13.83 $8.82 $13.66 $-6.63 $15.76 $10.63 $14.59 $15.97 $0.00